Lion Point Capital »

Neurocrine Biosciences shares owned by Lion Point Capital

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Lion Point Capital from 13F filings

Historical chart of Lion Point Capital investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Lion Point Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Lion Point Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.1M 8.4k 137.67
2024-03-31 $1.0M 7.5k 137.92

More positions owned by Lion Point Capital

Ishares Tr Russell 2000 Etf Put Option (IWM)
Ardelyx (ARDX)
Insmed Com Par $.01 (INSM)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Milestone Pharmaceuticals (MIST)
Geron Corporation (GERN)
Marinus Pharmaceuticals Com New (MRNS)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Mirum Pharmaceuticals Put Option (MIRM)
Syndax Pharmaceuticals (SNDX)
Bridgebio Pharma (BBIO)
Avadel Pharmaceuticals Com Shs (AVDL)
Neurocrine Biosciences (NBIX)
Fennec Pharmaceuticals (FENC)
Mineralys Therapeutics (MLYS)

View all positions for Lion Point Capital

Top funds holding Neurocrine Biosciences

BlackRock
BlackRock
Vanguard Group
State Street Corporation
Renaissance Technologies
Bellevue Group
Geode Capital Management
Citadel Advisors
AQR Capital Management
T. Rowe Price Associates
Morgan Stanley
Jpmorgan Chase & Co
Deerfield Management Company
Dodge & Cox
Goldman Sachs Group

View all funds holding Neurocrine Biosciences